European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries
The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR. Multi-center registry w...
Saved in:
| Published in | Journal of cardiovascular magnetic resonance Vol. 15; no. 1; p. 9 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Elsevier Inc
18.01.2013
BioMed Central BioMed Central Ltd Elsevier |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1097-6647 1532-429X 1532-429X |
| DOI | 10.1186/1532-429X-15-9 |
Cover
| Abstract | The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR.
Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled.
The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year).
The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM.
The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting in a large number of cases (n > 27000). Based on our data CMR is frequently performed in European daily clinical routine. The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. |
|---|---|
| AbstractList | The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR.
Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled.
The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year).
The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. Abstract Background The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR. Methods Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled. Results The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year). Conclusion The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. Condensed abstract The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting in a large number of cases (n > 27000). Based on our data CMR is frequently performed in European daily clinical routine. The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR. Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled. The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year). The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. Background The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR. Methods Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled. Results The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year). Conclusion The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. Condensed abstract The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting in a large number of cases (n > 27000). Based on our data CMR is frequently performed in European daily clinical routine. The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. Keywords: Cardiovascular magnetic resonance, Registry, Quality, Safety, Therapeutic implications, Impact, Patient management Background The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR. Methods Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled. Results The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year). Conclusion The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. Condensed abstract The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting in a large number of cases (n > 27000). Based on our data CMR is frequently performed in European daily clinical routine. The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR. Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled. The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year). The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting in a large number of cases (n > 27000). Based on our data CMR is frequently performed in European daily clinical routine. The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR.BACKGROUNDThe EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR.Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled.METHODSMulti-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled.The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year).RESULTSThe most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year).The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM.CONCLUSIONThe most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. Doc number: 9 Abstract Background: The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR. Methods: Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled. Results: The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year). Conclusion: The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. Condensed abstract: The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting in a large number of cases (n > 27000). Based on our data CMR is frequently performed in European daily clinical routine. The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. Background: The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR. Methods: Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled. Results: The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year). Conclusion: The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. Condensed abstract: The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting in a large number of cases (n > 27000). Based on our data CMR is frequently performed in European daily clinical routine. The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. |
| ArticleNumber | 9 |
| Audience | Academic |
| Author | van Rossum, Albert Monney, Pierre Prasad, Sanjay Dill, Thorsten Frank, Herbert Schumm, Julia Sabin, Georg Cagnolo, Alessandro Nothnagel, Detlev Steen, Henning Petersen, Steffen Schneider, Steffen Nagel, Eike Mahrholdt, Heiko Wagner, Anja Greulich, Simon Bruder, Oliver Lombardi, Massimo Schwitter, Jürg Pilz, Günter Deluigi, Christina C |
| AuthorAffiliation | 14 Department of Internal Medicine and Cardiology, Donauklinikum Tulln, Austria 10 King’s College London BHF Centre of Excellence, Division of Imaging Sciences, NIHR Biomedical Research Centre at Guy’s and St.Thomas’ NHS Trust Foundation, The Rayne Institute, St. Thomas’ Hospital, London, UK 11 CMR Unit, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK 13 Department of Internal Medicine, Krankenhaus Benrath, Düsseldorf, Germany 6 Department of Cardiology, Hospital Agatharied, Hausham, Germany 1 Department of Cardiology and Angiology, Contilia Heart and Vascular Center, Essen, Germany 3 C.N.R./Regione Toscana “G. Monasterio Foundation”, Pisa, Italy 4 Cardiac MR Centre, University Hospital (CHUV), Lausanne, Switzerland 12 Department of Cardiology, Robert Bosch Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany 2 Comprehensive Cardiology of Stamford and Greenwich, Stamford, CT, USA 5 Department of Cardiology, VU Medical Centre, Amsterdam, The Netherlands 8 Department of Cardio |
| AuthorAffiliation_xml | – name: 12 Department of Cardiology, Robert Bosch Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany – name: 14 Department of Internal Medicine and Cardiology, Donauklinikum Tulln, Austria – name: 9 Barts and The London NIHR Biomedical Research Unit, The London Chest Hospital, London, UK – name: 2 Comprehensive Cardiology of Stamford and Greenwich, Stamford, CT, USA – name: 15 Institut für Herzinfarktforschung, Ludwigshafen, Germany – name: 5 Department of Cardiology, VU Medical Centre, Amsterdam, The Netherlands – name: 6 Department of Cardiology, Hospital Agatharied, Hausham, Germany – name: 11 CMR Unit, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK – name: 13 Department of Internal Medicine, Krankenhaus Benrath, Düsseldorf, Germany – name: 8 Department of Cardiology, University of Heidelberg, Heidelberg, Germany – name: 7 Department of Cardiology, Klinikum Ludwigsburg, Germany – name: 3 C.N.R./Regione Toscana “G. Monasterio Foundation”, Pisa, Italy – name: 4 Cardiac MR Centre, University Hospital (CHUV), Lausanne, Switzerland – name: 1 Department of Cardiology and Angiology, Contilia Heart and Vascular Center, Essen, Germany – name: 10 King’s College London BHF Centre of Excellence, Division of Imaging Sciences, NIHR Biomedical Research Centre at Guy’s and St.Thomas’ NHS Trust Foundation, The Rayne Institute, St. Thomas’ Hospital, London, UK |
| Author_xml | – sequence: 1 givenname: Oliver surname: Bruder fullname: Bruder, Oliver organization: Department of Cardiology and Angiology, Contilia Heart and Vascular Center, Essen, Germany – sequence: 2 givenname: Anja surname: Wagner fullname: Wagner, Anja organization: Comprehensive Cardiology of Stamford and Greenwich, Stamford, CT, USA – sequence: 3 givenname: Massimo surname: Lombardi fullname: Lombardi, Massimo organization: C.N.R./Regione Toscana “G. Monasterio Foundation”, Pisa, Italy – sequence: 4 givenname: Jürg surname: Schwitter fullname: Schwitter, Jürg organization: Cardiac MR Centre, University Hospital (CHUV), Lausanne, Switzerland – sequence: 5 givenname: Albert surname: van Rossum fullname: van Rossum, Albert organization: Department of Cardiology, VU Medical Centre, Amsterdam, The Netherlands – sequence: 6 givenname: Günter surname: Pilz fullname: Pilz, Günter organization: Department of Cardiology, Hospital Agatharied, Hausham, Germany – sequence: 7 givenname: Detlev surname: Nothnagel fullname: Nothnagel, Detlev organization: Department of Cardiology, Klinikum Ludwigsburg, Germany – sequence: 8 givenname: Henning surname: Steen fullname: Steen, Henning organization: Department of Cardiology, University of Heidelberg, Heidelberg, Germany – sequence: 9 givenname: Steffen surname: Petersen fullname: Petersen, Steffen organization: Barts and The London NIHR Biomedical Research Unit, The London Chest Hospital, London, UK – sequence: 10 givenname: Eike surname: Nagel fullname: Nagel, Eike organization: King's College London BHF Centre of Excellence, Division of Imaging Sciences, NIHR Biomedical Research Centre at Guy's and St.Thomas' NHS Trust Foundation, The Rayne Institute, St. Thomas' Hospital, London, UK – sequence: 11 givenname: Sanjay surname: Prasad fullname: Prasad, Sanjay organization: CMR Unit, Royal Brompton Hospital, Sydney Street, SW3 6NP, London, UK – sequence: 12 givenname: Julia surname: Schumm fullname: Schumm, Julia organization: Department of Cardiology, Robert Bosch Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany – sequence: 13 givenname: Simon surname: Greulich fullname: Greulich, Simon organization: Department of Cardiology, Robert Bosch Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany – sequence: 14 givenname: Alessandro surname: Cagnolo fullname: Cagnolo, Alessandro organization: C.N.R./Regione Toscana “G. Monasterio Foundation”, Pisa, Italy – sequence: 15 givenname: Pierre surname: Monney fullname: Monney, Pierre organization: Cardiac MR Centre, University Hospital (CHUV), Lausanne, Switzerland – sequence: 16 givenname: Christina C surname: Deluigi fullname: Deluigi, Christina C organization: Department of Cardiology and Angiology, Contilia Heart and Vascular Center, Essen, Germany – sequence: 17 givenname: Thorsten surname: Dill fullname: Dill, Thorsten organization: Department of Internal Medicine, Krankenhaus Benrath, Düsseldorf, Germany – sequence: 18 givenname: Herbert surname: Frank fullname: Frank, Herbert organization: Department of Internal Medicine and Cardiology, Donauklinikum Tulln, Austria – sequence: 19 givenname: Georg surname: Sabin fullname: Sabin, Georg organization: Department of Cardiology and Angiology, Contilia Heart and Vascular Center, Essen, Germany – sequence: 20 givenname: Steffen surname: Schneider fullname: Schneider, Steffen organization: Institut für Herzinfarktforschung, Ludwigshafen, Germany – sequence: 21 givenname: Heiko surname: Mahrholdt fullname: Mahrholdt, Heiko email: heiko.mahrholdt@rbk.de organization: Department of Cardiology, Robert Bosch Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23331632$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFks9qFTEUxgep2D-6dSkBQepi2mSSyUw2QilVCxVBFNyF3MyZ29RMUpOZYne-g2_ok3imt7a9xSKzmHDy-77knHzbxUaIAYriOaN7jLVyn9W8KkWlvpasLtWjYuumsIFrqppSStFsFts5n1HKVEObJ8VmxTlnkldbxY-jKcVzMIFYkzoXL0y2kzeJDGYZYHSWJMgxmGCB7M7s4YdPr7G2dHlMl-T3z19kmPzoSDCjQ87PPBYy6VMcSN0QC2GElIkLhNXEximMyUF-Wjzujc_w7Pq_U3x5e_T58H158vHd8eHBSWkbWo0ltF0n6hYq3qhOypp2C8qMNdUCmIDOsoWqq7ZmfcNNz-pGVRUo1QO3nVywRct3iuOVbxfNmT5PbjDpUkfj9FUhpqU2Cfv0oCsQkjU1qA5q0UmloLecg7Ci5-jI0OvNyut8Wgx4OHaWjF8zXd8J7lQv44XmNT6CoGiwe22Q4vcJ8qgHly14bwLEKWvGsQVaCcb-j2LXtKWNFIi-vIeexSnhW1xRokJS8FtqabBXF_qIV7SzqT6ouZCtFFQitfcPCr8OBmcxe73D-prg1R3BKRg_nubopzkNeR18cXd4N1P7m8Xbo22KOSfobxBG9Rx2PWdbz9nGlVYoEPcE1o1XMcQ7O_-wbH8ly-gflpDujOshhVwpAIN64VBhvQvOGv8NLjFH7iHhH7VlIdo |
| CitedBy_id | crossref_primary_10_1097_RTI_0000000000000701 crossref_primary_10_1186_s12968_015_0195_0 crossref_primary_10_4330_wjc_v9_i2_92 crossref_primary_10_1016_j_ejrad_2013_10_006 crossref_primary_10_1136_heartjnl_2013_304680 crossref_primary_10_1097_HCO_0000000000000514 crossref_primary_10_1093_ehjci_jeaa345 crossref_primary_10_11604_pamj_2024_49_15_44617 crossref_primary_10_1007_s00330_018_5774_7 crossref_primary_10_1016_j_ahj_2013_08_018 crossref_primary_10_1186_s12968_014_0100_2 crossref_primary_10_1002_cce2_17 crossref_primary_10_1016_j_recesp_2019_02_004 crossref_primary_10_1016_j_repc_2013_10_005 crossref_primary_10_1016_j_jcmg_2017_01_003 crossref_primary_10_1016_j_jocmr_2024_101005 crossref_primary_10_1016_j_acra_2017_09_017 crossref_primary_10_5694_mja16_00438 crossref_primary_10_1002_jmri_25053 crossref_primary_10_1007_s00117_020_00765_4 crossref_primary_10_1007_s10554_021_02363_4 crossref_primary_10_1080_14779072_2021_1915130 crossref_primary_10_2217_fca_13_23 crossref_primary_10_1016_j_acmx_2016_07_002 crossref_primary_10_3389_fcvm_2021_683434 crossref_primary_10_1016_j_repce_2013_10_045 crossref_primary_10_1186_s12968_021_00833_1 crossref_primary_10_1161_CIRCIMAGING_119_008872 crossref_primary_10_1093_ehjci_jeu323 crossref_primary_10_1186_s12968_015_0168_3 crossref_primary_10_1016_j_jcmg_2021_07_029 crossref_primary_10_1002_ehf2_12442 crossref_primary_10_1161_CIRCIMAGING_117_006062 crossref_primary_10_3389_fcvm_2020_617771 crossref_primary_10_1007_s00330_019_06171_2 crossref_primary_10_1016_j_jcmg_2016_09_010 crossref_primary_10_1007_s40134_020_0344_6 crossref_primary_10_1016_j_ijcard_2013_06_032 crossref_primary_10_1186_s12968_016_0225_6 crossref_primary_10_1007_s11886_015_0563_2 crossref_primary_10_1136_heartjnl_2013_304324 crossref_primary_10_1053_j_semnuclmed_2024_02_008 crossref_primary_10_1186_s12968_015_0201_6 crossref_primary_10_3390_diagnostics14171946 crossref_primary_10_1002_jmri_25754 crossref_primary_10_1111_anec_12819 crossref_primary_10_2459_JCM_0000000000001016 crossref_primary_10_36290_vnl_2019_111 crossref_primary_10_1161_STROKEAHA_116_016227 crossref_primary_10_1136_postgradmedj_2013_304324rep crossref_primary_10_3348_kjr_2018_0243 crossref_primary_10_1161_CIRCIMAGING_120_010599 crossref_primary_10_1016_j_jacc_2019_07_074 crossref_primary_10_1093_eurheartj_ehx646 crossref_primary_10_3390_jcm12113793 crossref_primary_10_7861_clinmedicine_13_6_s3 crossref_primary_10_1001_jamacardio_2023_1290 crossref_primary_10_1161_CIR_0000000000001063 crossref_primary_10_1016_j_crvasa_2015_09_009 crossref_primary_10_1259_bjr_20150954 crossref_primary_10_1002_jmri_28460 crossref_primary_10_3390_jcm13040949 crossref_primary_10_1007_s10334_021_00923_2 crossref_primary_10_1016_j_jcmg_2021_02_031 crossref_primary_10_1016_j_rec_2019_02_007 crossref_primary_10_1136_heartjnl_2015_307764 crossref_primary_10_1186_s12968_017_0400_4 crossref_primary_10_1136_openhrt_2021_001700 crossref_primary_10_1136_postgradmedj_2016_134653 crossref_primary_10_1016_j_mric_2014_08_007 crossref_primary_10_1161_JAHA_121_022605 crossref_primary_10_1002_mrm_25249 crossref_primary_10_2217_fca_13_102 crossref_primary_10_1080_14779072_2018_1455499 crossref_primary_10_1016_j_jcmg_2014_04_016 crossref_primary_10_1016_j_jcmg_2017_02_006 crossref_primary_10_1016_j_jacc_2021_12_012 crossref_primary_10_1136_heartjnl_2015_307896 crossref_primary_10_1259_bjrcr_20140059 crossref_primary_10_1016_j_ijcard_2018_12_006 crossref_primary_10_1136_heartjnl_2020_318667 crossref_primary_10_1177_0284185116674501 crossref_primary_10_1016_j_jacc_2017_11_071 crossref_primary_10_1186_s12968_021_00714_7 crossref_primary_10_1148_ryct_220111 crossref_primary_10_1007_s10554_018_1494_y crossref_primary_10_1007_s13244_015_0444_7 crossref_primary_10_1007_s11883_016_0576_3 crossref_primary_10_1007_s00108_013_3385_6 crossref_primary_10_1161_CIRCIMAGING_113_001241 crossref_primary_10_1186_1532_429X_15_60 crossref_primary_10_1259_bjr_20150662 crossref_primary_10_3390_diagnostics13152598 crossref_primary_10_1016_j_rxeng_2020_01_002 crossref_primary_10_1016_j_jchf_2024_12_003 crossref_primary_10_3390_ijerph19084829 crossref_primary_10_1007_s11886_015_0599_3 crossref_primary_10_1007_s12181_015_0021_9 crossref_primary_10_1148_ryct_2019180017 crossref_primary_10_1002_jmri_26613 crossref_primary_10_1007_s00062_020_00897_z crossref_primary_10_1016_j_mri_2015_04_004 crossref_primary_10_1186_s12968_015_0222_1 crossref_primary_10_1097_RTI_0000000000000459 crossref_primary_10_1586_14779072_2014_910117 crossref_primary_10_1016_j_rx_2019_11_002 crossref_primary_10_1002_brb3_1620 crossref_primary_10_1161_CIRCULATIONAHA_121_054432 crossref_primary_10_1007_s12410_019_9484_6 crossref_primary_10_1186_s12968_016_0321_7 crossref_primary_10_1007_s00330_018_5432_0 crossref_primary_10_1093_ehjimp_qyae050 crossref_primary_10_3348_kjr_2021_0387 crossref_primary_10_1007_s00117_013_2533_2 crossref_primary_10_1259_bjr_20140059 crossref_primary_10_1002_jmri_25483 crossref_primary_10_1148_ryct_2020200102 crossref_primary_10_47803_rjc_2020_31_4_795 crossref_primary_10_1007_s00330_014_3213_y crossref_primary_10_1038_s41598_021_94311_4 crossref_primary_10_1093_ehjci_jey162 crossref_primary_10_1097_MNH_0000000000000952 crossref_primary_10_1111_aas_14234 crossref_primary_10_1186_s12968_015_0203_4 crossref_primary_10_1186_s12968_016_0246_1 crossref_primary_10_1109_JBHI_2014_2370952 crossref_primary_10_1186_s13063_017_2101_6 crossref_primary_10_1007_s12181_013_0546_8 crossref_primary_10_1016_j_rec_2021_09_016 crossref_primary_10_1186_1532_429X_16_13 crossref_primary_10_1136_openhrt_2018_000924 crossref_primary_10_1016_j_mric_2019_04_007 crossref_primary_10_1007_s00330_020_06971_x crossref_primary_10_1093_ehjqcco_qcw008 crossref_primary_10_3390_jcm13061556 crossref_primary_10_1016_j_jcmg_2014_09_003 crossref_primary_10_1161_JAHA_118_010435 crossref_primary_10_1016_j_cpcardiol_2017_04_005 crossref_primary_10_1186_s12872_017_0529_y crossref_primary_10_1186_s12968_017_0385_z crossref_primary_10_1161_JAHA_118_008981 crossref_primary_10_1007_s10554_014_0368_1 crossref_primary_10_1016_j_acvd_2021_06_004 crossref_primary_10_1016_j_mri_2015_12_027 crossref_primary_10_1007_s10554_021_02462_2 crossref_primary_10_1148_rg_2016150225 crossref_primary_10_1016_j_ijcard_2019_01_005 crossref_primary_10_1016_j_jcmg_2018_05_007 crossref_primary_10_1007_s12410_014_9278_9 crossref_primary_10_1016_j_ijcard_2016_04_158 crossref_primary_10_1186_1532_429X_15_55 crossref_primary_10_1016_j_ajem_2020_05_100 crossref_primary_10_1371_journal_pone_0292950 crossref_primary_10_1016_j_recesp_2021_09_015 crossref_primary_10_1097_RTI_0000000000000199 crossref_primary_10_1093_ehjci_jev308 crossref_primary_10_1002_jmri_26519 crossref_primary_10_1016_j_jcmg_2020_10_024 crossref_primary_10_1093_eurheartj_ehac035 crossref_primary_10_1186_s12916_014_0265_4 crossref_primary_10_1253_circj_CJ_14_0203 crossref_primary_10_1259_bjr_20150987 crossref_primary_10_1259_bjr_20200780 crossref_primary_10_1007_s10554_016_1012_z crossref_primary_10_26442_00403660_2021_04_200687 crossref_primary_10_1016_j_jcmg_2021_11_008 crossref_primary_10_1161_CIRCIMAGING_113_000416 crossref_primary_10_1093_ehjci_jev153 |
| Cites_doi | 10.1056/NEJMoa0806576 10.1161/CIRCULATIONAHA.105.570648 10.1093/eurheartj/ehn484 10.1016/j.jacc.2010.05.007 10.1016/0735-1097(92)90474-2 10.1016/j.jacc.2005.10.074 10.1016/j.jcmg.2010.11.012 10.1186/1532-429X-14-35 10.1016/j.jacc.2009.07.003 10.1016/j.jacc.2008.07.031 10.1016/j.jcmg.2011.11.021 10.1016/j.jacc.2007.03.028 10.1056/NEJM200106143442406 10.1161/01.CIR.0000118493.13323.81 10.1016/0002-9149(90)90616-9 10.1186/1532-429X-11-43 10.1161/01.CIR.97.18.1802 10.1056/NEJM200011163432003 10.1016/j.amjcard.2006.02.064 10.1016/j.jacc.2006.07.003 10.1161/CIRCULATIONAHA.105.606509 10.1016/S0140-6736(03)12389-6 10.1016/S0140-6736(11)61335-4 10.1148/radiol.2343031784 10.1016/j.jacc.2010.05.010 10.1161/CIRCULATIONAHA.106.652016 10.1161/hc2301.092121 10.1093/eurheartj/ehi258 |
| ContentType | Journal Article |
| Copyright | 2013 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance Bruder et al.; licensee BioMed Central Ltd. 2013 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. COPYRIGHT 2013 BioMed Central Ltd. 2013 Bruder et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2013 Bruder et al.; licensee BioMed Central Ltd. 2013 Bruder et al.; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: 2013 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance – notice: Bruder et al.; licensee BioMed Central Ltd. 2013 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: COPYRIGHT 2013 BioMed Central Ltd. – notice: 2013 Bruder et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2013 Bruder et al.; licensee BioMed Central Ltd. 2013 Bruder et al.; licensee BioMed Central Ltd. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7SC 7SP 7U5 7X7 7XB 88E 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ JQ2 K9. L7M LK8 L~C L~D M0S M1P M7P M7Z P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/1532-429X-15-9 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Computer and Information Systems Abstracts Electronics & Communications Abstracts Solid State and Superconductivity Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest SciTech Premium Collection Technology Collection Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection ProQuest One ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Computer Science Collection ProQuest Health & Medical Complete (Alumni) Advanced Technologies Database with Aerospace Biological Sciences Computer and Information Systems Abstracts Academic Computer and Information Systems Abstracts Professional ProQuest Health & Medical Collection Medical Database Biological Science Database Biochemistry Abstracts 1 Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ - The Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Computer Science Collection Computer and Information Systems Abstracts SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Electronics & Communications Abstracts ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Solid State and Superconductivity Abstracts Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Collection Technology Research Database Computer and Information Systems Abstracts – Academic ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Advanced Technologies Database with Aerospace ProQuest SciTech Collection Computer and Information Systems Abstracts Professional Advanced Technologies & Aerospace Database ProQuest Medical Library Biochemistry Abstracts 1 ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database Computer and Information Systems Abstracts |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-429X |
| EndPage | 9 |
| ExternalDocumentID | oai_doaj_org_article_2e46175e9de54d699efc33e4c4f3fe31 PMC3564740 2883758571 A534686406 23331632 10_1186_1532_429X_15_9 S1097664723007251 |
| Genre | Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
| GeographicLocations | Europe Germany |
| GeographicLocations_xml | – name: Europe – name: Germany |
| GroupedDBID | --- .1- .FO 0R~ 29K 2WC 36B 4.4 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ AAFWJ AALRI AAWTL AAXUO AAYWO ABDBF ABUWG ACGEJ ACGFO ACGFS ACIWK ACPRK ACVFH ADBBV ADCNI ADCVX ADRAZ ADUKV ADVLN ADXPE AENEX AEUPX AFJKZ AFKRA AFPKN AFPUW AFRAH AFRHN AHBYD AHMBA AHSBF AHYZX AIGII AITUG AJUYK AJWEG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMKLP AMRAJ AMTXH AOIJS ARAPS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 D-I DIK DU5 E3Z EAP EBS EJD EMB EMK EMOBN EST ESX F5P FDB FRP FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR IHW INR IPNFZ KQ8 LK8 M1P M41 M48 M7P O5R O5S OK1 OVT P2P P62 P6G PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RIG RNS ROL RPM RSV SMD SOJ SV3 TDBHL TFW TR2 TUS UKHRP Z5R ZCN EBLON 2VQ AAYXX ACUHS AFCTW ALIPV APXCP AWYRJ CAG CITATION COF EBC EBD HZ~ O9- -5E -5G -A0 -BR 3V. ACRMQ ADINQ C24 CGR CUY CVF EAD ECM EIF INH M~E NPM PMFND 7SC 7SP 7U5 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ JQ2 K9. L7M L~C L~D M7Z P64 PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c702t-e8dd458e2379d6650db01aca2be14edc1b952851f73af157922e99fe3cd6b1b83 |
| IEDL.DBID | BENPR |
| ISSN | 1097-6647 1532-429X |
| IngestDate | Wed Aug 27 01:01:38 EDT 2025 Thu Aug 21 14:08:26 EDT 2025 Sun Sep 28 08:54:02 EDT 2025 Sat Sep 27 18:57:45 EDT 2025 Fri Jul 25 10:47:29 EDT 2025 Tue Jun 17 22:04:54 EDT 2025 Tue Jun 10 21:01:04 EDT 2025 Thu May 22 21:23:54 EDT 2025 Wed Feb 19 02:08:54 EST 2025 Tue Jul 01 02:54:36 EDT 2025 Thu Apr 24 23:02:31 EDT 2025 Sat Sep 06 07:28:48 EDT 2025 Tue Aug 26 20:25:39 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Impact Cardiovascular magnetic resonance Therapeutic implications Quality Registry Safety Patient management |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c702t-e8dd458e2379d6650db01aca2be14edc1b952851f73af157922e99fe3cd6b1b83 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| OpenAccessLink | https://www.proquest.com/docview/1284228543?pq-origsite=%requestingapplication%&accountid=15518 |
| PMID | 23331632 |
| PQID | 1284228543 |
| PQPubID | 55371 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_2e46175e9de54d699efc33e4c4f3fe31 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3564740 proquest_miscellaneous_1315702411 proquest_miscellaneous_1285080764 proquest_journals_1284228543 gale_infotracmisc_A534686406 gale_infotracacademiconefile_A534686406 gale_healthsolutions_A534686406 pubmed_primary_23331632 crossref_primary_10_1186_1532_429X_15_9 crossref_citationtrail_10_1186_1532_429X_15_9 springer_journals_10_1186_1532_429X_15_9 elsevier_clinicalkey_doi_10_1186_1532_429X_15_9 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2013-01-18 |
| PublicationDateYYYYMMDD | 2013-01-18 |
| PublicationDate_xml | – month: 01 year: 2013 text: 2013-01-18 day: 18 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England – name: New York |
| PublicationTitle | Journal of cardiovascular magnetic resonance |
| PublicationTitleAbbrev | J Cardiovasc Magn Reson |
| PublicationTitleAlternate | J Cardiovasc Magn Reson |
| PublicationYear | 2013 |
| Publisher | Elsevier Inc BioMed Central BioMed Central Ltd Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: BioMed Central – name: BioMed Central Ltd – name: Elsevier |
| References | Greenwood, Maredia, Younger, Brown, Nixon, Everett, Bijsterveld, Ridgway, Radjenovic, Dickinson, Ball, Plein (bib10) 2012; 379 Kim, Wu, Rafael, Chen, Parker, Simonetti, Klocke, Bonow, Judd (bib7) 2000; 343 Varga, Garcia, Picano (bib17) 2006; 98 Green, Berger, Kramer, Salerno (bib30) 2012; 5 Wagner, Mahrholdt, Holly, Elliott, Regenfus, Parker, Klocke, Bonow, Kim, Judd (bib6) 2003; 361 Lee, Boucher (bib19) 2001; 344 Bertaso, Richardson, Wong, Cunnington, Nelson, Tayeb, Williams, Chew, Worthley, Teo, Worthley (bib27) 2012 Kramer, Barkhausen, Flamm, Kim, Nagel (bib4) 2008; 10 Berman, Kiat, Van Train, Friedman, Garcia, Maddahi (bib23) 1990; 66 Hendel, Patel, Kramer, Poon, Hendel, Carr, Gerstad, Gillam, Hodgson, Kim, Kramer, Lesser, Martin, Messer, Redberg, Rubin, Rumsfeld, Taylor, Weigold, Woodard, Brindis, Hendel, Douglas, Peterson, Wolk, Allen, Patel (bib3) 2006; 48 Gupta, Esterbrooks, Hilleman, Mohiuddin (bib18) 1992; 19 Cheng, Pegg, Karamitsos, Searle, Jerosch-Herold, Choudhury, Banning, Neubauer, Robson, Selvanayagam (bib15) 2007; 49 Mahrholdt, Wagner, Judd, Sechtem, Kim (bib11) 2005; 26 Bruder, Schneider, Nothnagel, Dill, Hombach, Schulz-Menger, Nagel, Lombardi, van Rossum, Wagner, Schwitter, Senges, Sabin, Sechtem, Mahrholdt (bib1) 2009; 54 Jenkins, Moir, Chan, Rakhit, Haluska, Marwick (bib20) 2009; 30 Moschetti, Muzzarelli, Pinget, Wagner, Pilz, Wasserfallen, Schulz-Menger, Nothnagel, Dill, Frank, Lombardi, Bruder, Mahrholdt, Schwitter (bib24) 2012; 14 Ricciardi, Wu, Davidson, Choi, Klocke, Bonow, Judd, Kim (bib5) 2001; 103 Mahrholdt, Goedecke, Wagner, Meinhardt, Athanasiadis, Vogelsberg, Fritz, Klingel, Kandolf, Sechtem (bib12) 2004; 109 Mahrholdt, Wagner, Deluigi, Kispert, Hager, Meinhardt, Vogelsberg, Fritz, Dippon, Bock, Klingel, Kandolf, Sechtem (bib13) 2006; 114 Bruder, Wagner, Jensen, Schneider, Ong, Kispert, Nassenstein, Schlosser, Sabin, Sechtem, Mahrholdt (bib28) 2010; 56 Klem, Heitner, Shah, Sketch, Behar, Weinsaft, Cawley, Parker, Elliott, Judd, Kim (bib8) 2006; 47 Kwong, Chan, Brown, Chan, Reynolds, Tsang, Davis (bib9) 2006; 113 Budoff, Dowe, Jollis, Gitter, Sutherland, Halamert, Scherer, Bellinger, Martin, Benton, Delago, Min (bib22) 2008; 52 O'Hanlon, Grasso, Roughton, Moon, Clark, Wage, Webb, Kulkarni, Dawson, Sulaibeekh, Chandrasekaran, Bucciarelli-Ducci, Pasquale, Cowie, McKenna, Sheppard, Elliott, Pennell, Prasad (bib29) 2010; 56 Sommer, Hackenbroch, Hofer, Schmiedel, Willinek, Flacke, Gieseke, Träber, Fimmers, Litt, Schild (bib16) 2005; 234 Kelle, Chiribiri, Vierecke, Egnell, Hamdan, Jahnke, Paetsch, Wellnhofer, Fleck, Klein, Gebker (bib26) 2011; 4 Friedrich, Strohm, Schulz-Menger, Marciniak, Luft, Dietz (bib14) 1998; 97 Miller, Rochitte, Dewey (bib21) 2008; 359 Wagner, Bruder, Schneider, Nothnagel, Buser, Pons-Lado, Dill, Hombach, Lombardi, van Rossum, Schwitter, Senges, Sabin, Sechtem, Mahrholdt, Nagel (bib2) 2009; 11 Jahnke, Nagel, Gebker, Kokocinski, Kelle, Manka, Fleck, Paetsch (bib25) 2007; 115 Kwong (10.1186/1532-429X-15-9_bib9) 2006; 113 Mahrholdt (10.1186/1532-429X-15-9_bib13) 2006; 114 Mahrholdt (10.1186/1532-429X-15-9_bib11) 2005; 26 Ricciardi (10.1186/1532-429X-15-9_bib5) 2001; 103 Kim (10.1186/1532-429X-15-9_bib7) 2000; 343 Wagner (10.1186/1532-429X-15-9_bib6) 2003; 361 Gupta (10.1186/1532-429X-15-9_bib18) 1992; 19 Varga (10.1186/1532-429X-15-9_bib17) 2006; 98 Klem (10.1186/1532-429X-15-9_bib8) 2006; 47 Kramer (10.1186/1532-429X-15-9_bib4) 2008; 10 O'Hanlon (10.1186/1532-429X-15-9_bib29) 2010; 56 Budoff (10.1186/1532-429X-15-9_bib22) 2008; 52 Green (10.1186/1532-429X-15-9_bib30) 2012; 5 Hendel (10.1186/1532-429X-15-9_bib3) 2006; 48 Bruder (10.1186/1532-429X-15-9_bib1) 2009; 54 Moschetti (10.1186/1532-429X-15-9_bib24) 2012; 14 Miller (10.1186/1532-429X-15-9_bib21) 2008; 359 Bruder (10.1186/1532-429X-15-9_bib28) 2010; 56 Greenwood (10.1186/1532-429X-15-9_bib10) 2012; 379 Mahrholdt (10.1186/1532-429X-15-9_bib12) 2004; 109 Wagner (10.1186/1532-429X-15-9_bib2) 2009; 11 Jahnke (10.1186/1532-429X-15-9_bib25) 2007; 115 Bertaso (10.1186/1532-429X-15-9_bib27) 2012 Cheng (10.1186/1532-429X-15-9_bib15) 2007; 49 Friedrich (10.1186/1532-429X-15-9_bib14) 1998; 97 Berman (10.1186/1532-429X-15-9_bib23) 1990; 66 Lee (10.1186/1532-429X-15-9_bib19) 2001; 344 Sommer (10.1186/1532-429X-15-9_bib16) 2005; 234 Jenkins (10.1186/1532-429X-15-9_bib20) 2009; 30 Kelle (10.1186/1532-429X-15-9_bib26) 2011; 4 |
| References_xml | – year: 2012 ident: bib27 article-title: Prognostic value of adenosine stress perfusion cardiac MRI with late gadolinium enhancement in an intermediate cardiovascular risk population publication-title: Int J Cardiol – volume: 359 start-page: 2324 year: 2008 end-page: 2336 ident: bib21 article-title: 21. Diagnostic performance of coronary angiography by 64-row CT publication-title: N Engl J Med – volume: 10 start-page: 35 year: 2008 ident: bib4 article-title: Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trusteestask force on standardized protocols publication-title: JCMR – volume: 30 start-page: 98 year: 2009 end-page: 106 ident: bib20 article-title: Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging publication-title: Eur Heart J – volume: 56 start-page: 867 year: 2010 end-page: 874 ident: bib29 article-title: Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy publication-title: J Am Coll Cardiol – volume: 361 start-page: 374 year: 2003 end-page: 379 ident: bib6 article-title: Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study publication-title: Lancet – volume: 5 start-page: 370 year: 2012 end-page: 377 ident: bib30 article-title: Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy publication-title: JACC Cardiovasc Imaging – volume: 113 start-page: 2733 year: 2006 end-page: 2743 ident: bib9 article-title: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease publication-title: Circulation – volume: 109 start-page: 1250 year: 2004 end-page: 1258 ident: bib12 article-title: Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology publication-title: Circulation – volume: 14 start-page: 36 year: 2012 ident: bib24 article-title: Cost evaluation of cardiovascular magnetic resonance versus coronary angiography for the diagnostic work-up of coronary artery disease: Application of the European Cardiovascular Magnetic Resonance registry data to the German, United Kingdom, Swiss, and United States health care systems publication-title: J Cardiovasc Magn Reson – volume: 54 start-page: 1457 year: 2009 end-page: 1466 ident: bib1 article-title: EuroCMR (European cardiovascular magnetic resonance) registry: results of the German pilot phase publication-title: J Am Coll Cardiol – volume: 49 start-page: 2440 year: 2007 end-page: 2449 ident: bib15 article-title: Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla publication-title: J Am Coll Cardiol – volume: 66 start-page: 72E year: 1990 end-page: 729 ident: bib23 article-title: Comparison of SPECT using technetium-99 m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability publication-title: Am J Cardiol – volume: 26 start-page: 1461 year: 2005 end-page: 1474 ident: bib11 article-title: Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies publication-title: Eur Heart J – volume: 98 start-page: 541 year: 2006 end-page: 543 ident: bib17 article-title: Safety of stress echocardiography (from the International Stress Echo Complication Registry) publication-title: Am J Cardiol – volume: 4 start-page: 161 year: 2011 end-page: 172 ident: bib26 article-title: Long-term prognostic value of dobutamine stress CMR publication-title: JACC Cardiovasc Imaging – volume: 234 start-page: 718 year: 2005 end-page: 725 ident: bib16 article-title: Coronary MR angiography at 3.0 T versus that at 1.5 T: initial results in patients suspected of having coronary artery disease publication-title: Radiology – volume: 48 start-page: 1475 year: 2006 end-page: 1497 ident: bib3 article-title: ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology publication-title: J Am Coll Cardiol – volume: 11 start-page: 43 year: 2009 ident: bib2 article-title: Current Variables, Definitions and Endpoints of the European Cardiovascular Magnetic Resonance Imaging Registry publication-title: J Cardiovasc Magn Reson – volume: 19 start-page: 248 year: 1992 end-page: 257 ident: bib18 article-title: Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group. publication-title: J Am Coll Cardiol – volume: 103 start-page: 2780 year: 2001 end-page: 2783 ident: bib5 article-title: Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation publication-title: Circulation – volume: 114 start-page: 1581 year: 2006 end-page: 1590 ident: bib13 article-title: Presentation, patterns of myocardial damage, and clinical course of viral myocarditis publication-title: Circulation – volume: 52 start-page: 1724 year: 2008 end-page: 1732 ident: bib22 article-title: Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial publication-title: J Am Coll Cardiol – volume: 115 start-page: 1769 year: 2007 end-page: 1776 ident: bib25 article-title: Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging publication-title: Circulation – volume: 343 start-page: 1445 year: 2000 end-page: 1453 ident: bib7 article-title: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction publication-title: N Engl J Med – volume: 379 start-page: 453 year: 2012 end-page: 460 ident: bib10 article-title: Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial publication-title: Lancet – volume: 97 start-page: 1802 year: 1998 end-page: 1809 ident: bib14 article-title: Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis publication-title: Circulation – volume: 47 start-page: 1630 year: 2006 end-page: 1638 ident: bib8 article-title: Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging publication-title: J Am Coll Cardiol – volume: 56 start-page: 875 year: 2010 end-page: 887 ident: bib28 article-title: Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients with Hypertrophic Cardiomyopathy publication-title: J Am Coll Cardiol – volume: 344 start-page: 1840 year: 2001 end-page: 1845 ident: bib19 article-title: Clinical practice. Noninvasive tests in patients with stable coronary artery disease publication-title: N Engl J Med – volume: 359 start-page: 2324 year: 2008 ident: 10.1186/1532-429X-15-9_bib21 article-title: 21. Diagnostic performance of coronary angiography by 64-row CT publication-title: N Engl J Med doi: 10.1056/NEJMoa0806576 – volume: 113 start-page: 2733 year: 2006 ident: 10.1186/1532-429X-15-9_bib9 article-title: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.570648 – volume: 30 start-page: 98 year: 2009 ident: 10.1186/1532-429X-15-9_bib20 article-title: Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging publication-title: Eur Heart J doi: 10.1093/eurheartj/ehn484 – volume: 56 start-page: 875 year: 2010 ident: 10.1186/1532-429X-15-9_bib28 article-title: Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients with Hypertrophic Cardiomyopathy publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.05.007 – volume: 19 start-page: 248 year: 1992 ident: 10.1186/1532-429X-15-9_bib18 article-title: Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group. publication-title: J Am Coll Cardiol doi: 10.1016/0735-1097(92)90474-2 – volume: 47 start-page: 1630 year: 2006 ident: 10.1186/1532-429X-15-9_bib8 article-title: Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2005.10.074 – volume: 4 start-page: 161 issue: 2 year: 2011 ident: 10.1186/1532-429X-15-9_bib26 article-title: Long-term prognostic value of dobutamine stress CMR publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2010.11.012 – volume: 14 start-page: 36 issue: 1 year: 2012 ident: 10.1186/1532-429X-15-9_bib24 publication-title: J Cardiovasc Magn Reson doi: 10.1186/1532-429X-14-35 – volume: 54 start-page: 1457 year: 2009 ident: 10.1186/1532-429X-15-9_bib1 article-title: EuroCMR (European cardiovascular magnetic resonance) registry: results of the German pilot phase publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.07.003 – volume: 52 start-page: 1724 year: 2008 ident: 10.1186/1532-429X-15-9_bib22 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.07.031 – volume: 5 start-page: 370 year: 2012 ident: 10.1186/1532-429X-15-9_bib30 article-title: Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2011.11.021 – volume: 49 start-page: 2440 year: 2007 ident: 10.1186/1532-429X-15-9_bib15 article-title: Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.03.028 – volume: 344 start-page: 1840 year: 2001 ident: 10.1186/1532-429X-15-9_bib19 article-title: Clinical practice. Noninvasive tests in patients with stable coronary artery disease publication-title: N Engl J Med doi: 10.1056/NEJM200106143442406 – volume: 109 start-page: 1250 year: 2004 ident: 10.1186/1532-429X-15-9_bib12 article-title: Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology publication-title: Circulation doi: 10.1161/01.CIR.0000118493.13323.81 – volume: 66 start-page: 72E year: 1990 ident: 10.1186/1532-429X-15-9_bib23 article-title: Comparison of SPECT using technetium-99 m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability publication-title: Am J Cardiol doi: 10.1016/0002-9149(90)90616-9 – volume: 10 start-page: 35 year: 2008 ident: 10.1186/1532-429X-15-9_bib4 article-title: Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trusteestask force on standardized protocols publication-title: JCMR – volume: 11 start-page: 43 year: 2009 ident: 10.1186/1532-429X-15-9_bib2 article-title: Current Variables, Definitions and Endpoints of the European Cardiovascular Magnetic Resonance Imaging Registry publication-title: J Cardiovasc Magn Reson doi: 10.1186/1532-429X-11-43 – volume: 97 start-page: 1802 year: 1998 ident: 10.1186/1532-429X-15-9_bib14 article-title: Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis publication-title: Circulation doi: 10.1161/01.CIR.97.18.1802 – volume: 343 start-page: 1445 year: 2000 ident: 10.1186/1532-429X-15-9_bib7 article-title: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction publication-title: N Engl J Med doi: 10.1056/NEJM200011163432003 – volume: 98 start-page: 541 year: 2006 ident: 10.1186/1532-429X-15-9_bib17 article-title: Safety of stress echocardiography (from the International Stress Echo Complication Registry) publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2006.02.064 – volume: 48 start-page: 1475 year: 2006 ident: 10.1186/1532-429X-15-9_bib3 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.07.003 – volume: 114 start-page: 1581 year: 2006 ident: 10.1186/1532-429X-15-9_bib13 article-title: Presentation, patterns of myocardial damage, and clinical course of viral myocarditis publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.606509 – volume: 361 start-page: 374 year: 2003 ident: 10.1186/1532-429X-15-9_bib6 article-title: Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study publication-title: Lancet doi: 10.1016/S0140-6736(03)12389-6 – volume: 379 start-page: 453 year: 2012 ident: 10.1186/1532-429X-15-9_bib10 article-title: Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial publication-title: Lancet doi: 10.1016/S0140-6736(11)61335-4 – volume: 234 start-page: 718 year: 2005 ident: 10.1186/1532-429X-15-9_bib16 article-title: Coronary MR angiography at 3.0 T versus that at 1.5 T: initial results in patients suspected of having coronary artery disease publication-title: Radiology doi: 10.1148/radiol.2343031784 – volume: 56 start-page: 867 issue: 11 year: 2010 ident: 10.1186/1532-429X-15-9_bib29 article-title: Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.05.010 – volume: 115 start-page: 1769 year: 2007 ident: 10.1186/1532-429X-15-9_bib25 article-title: Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.652016 – volume: 103 start-page: 2780 year: 2001 ident: 10.1186/1532-429X-15-9_bib5 article-title: Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation publication-title: Circulation doi: 10.1161/hc2301.092121 – year: 2012 ident: 10.1186/1532-429X-15-9_bib27 article-title: Prognostic value of adenosine stress perfusion cardiac MRI with late gadolinium enhancement in an intermediate cardiovascular risk population publication-title: Int J Cardiol – volume: 26 start-page: 1461 year: 2005 ident: 10.1186/1532-429X-15-9_bib11 article-title: Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies publication-title: Eur Heart J doi: 10.1093/eurheartj/ehi258 |
| SSID | ssj0019707 |
| Score | 2.468847 |
| Snippet | The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national... Background The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a... Background The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a... Doc number: 9 Abstract Background: The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical... Background: The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a... Abstract Background The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 9 |
| SubjectTerms | Aged Angiology Assessments Biomedical research Cardiology Cardiovascular disease Cardiovascular diseases Cardiovascular magnetic resonance Chi-Square Distribution Clinical medicine Computer aided design Diagnosis Europe Female Heart attacks Heart Diseases - diagnosis Heart Diseases - mortality Heart Diseases - pathology Heart Diseases - physiopathology Heart Diseases - therapy Heart muscle Humans Hypothesis testing Image quality Imaging Impact Indication Internal medicine Ischemia Kaplan-Meier Estimate Magnetic resonance imaging Magnetic Resonance Imaging - adverse effects Male Management Management science Medical imaging Medicine Medicine & Public Health Middle Aged Myocardium - pathology Patient management Patients Physiological aspects Predictive Value of Tests Prognosis Quality Radiology Registries Registry Risk Assessment Risk Factors Routines Safety Severity of Illness Index Stratification Studies Therapeutic implications Tissue Survival Trends |
| SummonAdditionalLinks | – databaseName: DOAJ - The Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yB_Eivm1dNYLgegjTeSfHdXFZhPEgLswtdHfSOqA94s6CR_-D_9BfYlX6wfTg6sXb0Kme7tQ7ndRXhLxQtWgVBH5WK18z1VSC-cpIpnWE8GxklBl2cfnOnJ2rtyu92mn1hWfCenjgnnELkRQEWZ18TFpF431qGymTalQr276CWpS-HBdTw_6Bt7lQGrdXmTHKDnCN3JkFmLhg4IVXjGvmZ-Eoo_bPotK-m96JU_tnKPc2UnN8Or1Fbg6JJT3uJ3SbXEvdHXJ9OWyd3yXfx-_utJkdQaVfqo8dVjJSWHhvEH4j0SOkPVm-f0WxbwO2g6O_fvyk-fAhHT8fIj1cuKBYoUK1pfiOkEzSdUe5prkJBa7D75Hz0zcfTs7Y0HaBNbYUW5ZcjEq7JKT10UAGF-uSVyDFOnEFE-a11wIStdbKquXaeiGS9yCLJpqa107eJwfdpksPCTwY7nfGVM5Y0IVYtZAu6lYkI5JOyRaEjdwPzYBJjq0xPoe8NnEmoLQCSgt-BV-QlxP91x6N40rK1yjMiQpRtPMF0K0w6Fb4l24VZDGqQhgLVcG1wh-tr3zsM9SY0BexTt4jHGupjDOQPcEUMgX6D5hqUw1lEMAwROKaUR7OKMHum_nwqJVh8DsXAbMNgUWxsiDPp2G8E8_SdWlzmWnAOEtr1F9oJAgW0jcOPHjQK_rESiGlhCxeFMTOTGDG6_lIt_6UkculBltUZUGORmPZefU_MvTR_5DjY3JD5C4mnHF3SA623y7TE8glt_XT7DZ-AzsKbg4 priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgLojwDBYyERDmYrt_xAVWloqqQlgNipb1ZSey0K5UsbLeI_vvOeJO0WdreVsl4E4_n8TmeByHvVSlqBY6flcqVTFWFYK4wkmkdwD0bGWQquzj-bg4n6ttUTy_jn1oGnl67tcN-UpPFyad_f853QeE_J4XPzQ4orWBgV6eMa-buknvprAjD-NTliYKzKXUaD1yZMcq2BRz_Hz9wUKmO_8BPrRvuK55rPapy7Wg1eayDR-RhCzXp3ko2Nsmd2Dwm98ftYfoT8rf7Ek-rQVAq_VUcNZjbSGErPseCHJFuI-3--MdHip0csEEcZTQFI9LucyJSw4VTihkrVFuKbwjgks4ayjVNTSlwX_6UTA6-_tw_ZG0bBlbZkViymIegdB6FtC4YQHShHPECVrWMXMF0eem0AOBWW1nUXFsnRHSujrIKpuRlLp-RjWbexBcEHgzjc2OK3FiQjVDUAB91LaIRUcdoM8I63vuqrVGOrTJOfNqr5MbjWnlcK_jlXUY-9PS_V9U5bqT8gkvZU2FV7XRhvjjyrZJ6ERUAOh1diFoF41ysKymjqlQtYT48IzudIPgucRVMLfzR7MbHvkV58auk1t6a-D0tlckNoCmYQqJACYepVkWbFgEMw8pcA8qtASXYgWp4u5NJ36mRR_QhMElWZuRdfxtHYmxdE-dniQaUdWSNuoVGwsICnOPAg-crMe9ZKaSUgOpFRuxAAQa8Ht5pZsepkrnUoIlqlJHtTlWuvPq1DH15-yxfkQci9SvhjOdbZGO5OIuvATUuyzfJHFwAWCBlZA priority: 102 providerName: Scholars Portal – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9QwFA66gvgi3q2uGkFwfQjb3JvHdXBZhPFBXJi30DSpDmhH3FnYx_0P_kN_iedk2jIdXfFtaL9Mm3NPk3MOIa9UEK0Cx8-CcoGpphbM1UYyrSO4ZyOjzGUX5x_Myal6v9CL_oAs5sJs79_zyhyCQgoGNnPBuGbuOrmhweiiJM_MbNwtcLa0fUHGP8dMHE6uyz_xO7uGeMsT7Z6S3NkqzR7o-A653YeO9GjD67vkWurukZvzfnP8PrkYvqzTZnLIlH6rP3eYq0hhab3CAhuJHiB2Nv_4hmJnBmz4Rn9d_qT5eCEdPhAiHi6cUcxBodpSfEcIF-myo1zT3GYCV9oPyOnxu0-zE9Y3VmCNLcWapSpGpaskpHXRQIwWQ8lr4FNIXMGEeXBaQCjWWlm3XFsnRHKuTbKJJvBQyYdkr1t16TGBB8P4ypi6Mha4HesWAkLdimRE0inZgrCB-r7pq45j84uvPq8-KuORWx65Bb-8K8jrEf99U2_jSuRbZOaIwjrZ-QKIj-_VzoukIETTycWkVTTOpbaRMqlGtRLmwwtyOIiCH1JRwXjCHy2vfOwLlBi_SVMd7YM_0lKZykB8BFPICLQQMNWm7hMdgGBYa2uC3J8gQbOb6e1BKn1vWc48xhMC015lQV6Ot3Eknpbr0uo8Y0D9SmvUPzASGAsBGgcaPNoI-khKIaWEOF0UxE5UYELr6Z1u-SXXJpfaKKvKghwMyrL16n8l6JP_hz4lt0TuRsIZr_bJ3vrHeXoGMeE6PM8G4TdtMlob priority: 102 providerName: Springer Nature |
| Title | European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1097664723007251 https://link.springer.com/article/10.1186/1532-429X-15-9 https://www.ncbi.nlm.nih.gov/pubmed/23331632 https://www.proquest.com/docview/1284228543 https://www.proquest.com/docview/1285080764 https://www.proquest.com/docview/1315702411 https://pubmed.ncbi.nlm.nih.gov/PMC3564740 https://doaj.org/article/2e46175e9de54d699efc33e4c4f3fe31 |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEF61qYS4IN4YSlgkJMphlezbe0CojRoqpESoolJulu1dt5HAKW3K72dmY5s6or1YiT1-7MzON7OPmSHkgypEpcDws0K5gqkyF8zlRjKtPZhnI72MaRdnc3Nypr4t9GKHzNtYGNxW2WJiBGq_KnGOfIQ4KjDcT365_M2wahSurrYlNPKmtIL_HFOM7ZI9gGQ9HpC9o-P599NuXcHZGECNy67MGGWbNI48NSNQfcEAnReMa-Z6Zipm8-9Zq234vmW_tvdWbi2wRrs1fUweNQ4nPdz0kCdkJ9RPyYNZs6T-jPxp5-Np2duaSn_l5zVGOFIYkK8wLUegB0g7mZ1-oljPAcvEUUbjlkTaTioiNZy4phi3QrWl-IXgYtJlTbmmkX84On9OzqbHPyYnrCnGwEo7FmsWUu-VToOQ1nkDfp0vxjwH2RaBK2guL5wG8fDKyrzi2johgnNVkKU3BS9S-YIM6lUdXhF4MdyfGpOnxkIP8XkFTqSuRDAi6BBsQljL-6xsMpVjwYyfWRyxpCZDWWUoK_iVuYR87OgvNzk67qQ8QlF2VJhbO55YXZ1njapmIihw63RwPmjljXOhKqUMqlSVhPbwhIzajpC14asAuPCg5Z2vfYf9JduEtnaYkh1qqUxqwKeCJkQKRBVoapk3wRHAMMzP1aPc71ECGpT9y22fzBo0us7-6U5C3neX8U7cYVeH1U2kAZUdW6PuoZEgWHDqOPDg5aabd6wUUkrw7UVCbE8BerzuX6mXFzGfudSgiWqckINWVW59-n8Z-vr-Vr4hD0WsWsIZT_fJYH11E96C77guhmTXLiwc0-nXYQMO8G9iJsM4GwPHmUr_Ahj_biQ |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9RAEN8gJOqL8dtTlDXRiA-bu_1s94EYQAgIdzEEkntb2-4WSbSHx6Hxn_Nvc2avrZQIb7w13Wn3Y2Z_M_sxM4S8UbkoFSh-liubM1VkgtnMSKa1B_VspJcx7OJwZHaO1KexHi-QP40vDF6rbDAxArWfFLhH3kccFejuJz-c_mCYNQpPV5sUGlmdWsGvxRBjtWPHXvj9C5ZwZ2u7H4Hfb4XY3jrc3GF1lgFWJAMxYyH1Xuk0CJlYb8Bg8fmAZ9DoPHAVfMFzq6FeXiYyK7lOrBDB2jLIwpuc56mE_94iSwo3UBbJ0sbW6PNBe45hk-iwjce8zBiV1GEjeWr6ADWCgTYYM66Z7ajFmD2gox0vq4sL-vLyXc5LB7pRT27fJ_dqA5euzyXyAVkI1UNye1gf4T8iP5v9f1p0rsLS79lxhR6VdBpweQDCSFeRdnN48J5i_ghMS0cZjVcgabOJidTw4oyinwzVCcUWgklLTyrKNY38wt2Ax-ToRtjyhCxWkyo8I1AxfJ8ak6UmAYn0WQlGqy5FMCLoEJIeYc3Yu6KOjI4JOr65uEJKjUNeOeQVPDnbI-9a-tN5TJArKTeQlS0VxvKOLybTY1dDgxNBgRmpg_VBK2-sDWUhZVCFKiX0h_dIvxEE17jLAsDDj06urHYF5cXNXWlbDHPrWiqTGrDhoAuRAlEMulpktTMGDBjGA-tQLncoAX2KbnEjk65GvzP3b672yOu2GL_EG31VmJxHGoCIQWLUNTQSGAtGJIcxeDoX83YohZQS1hKiR5LOBOiMdbekOvka46dLDTNRDXpktZkqF5r-3wF9fn0vV8idncPhvtvfHe29IHdFzJjCGU-XyeJseh5egt06y1_V4EDJl5vGo78pEaci |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1JaxRBFC5ihOBF3NNJNCUIxkMxU3sXeImjQ1wmiBiYW9FLdRzQnpBMwKP_wX_oL_G96oX0aMTb0P3VdNert1XXWwh5pnJRKTD8LFcuZ6rIBHOZkUzrEsyzkaWMZRdnx-boRL2b6_kGednlwsRo9-5IsslpwCpN9Wp0VlaNiKdmBGIqGGjSOeOauRvkJtbpwoC-iZn0ZwjOjm1bpvHPMQMzFKv1D6zRunq-Yp_WYyfXDlCjXZreIbdbh5IeNhxwl2yE-h7ZmrVH5vfJ9-57Oy0Goaf0W3ZaYwYjhQ33EstuBHqA2Mns0wuK_RqwDRz99eMnjUGHtPtsiHi4cEExM4VqS_EdwYmki5pyTWPzCdx_PyAn0zefJ0esbbfACjsWKxbSslQ6DUJaVxrw3Mp8zDNYvTxwBRPmudMCHLTKyqzi2johgnNVkEVpcp6n8iHZrJd12CbwYBifGpOlxgIPlFkFbqKuRDAi6BBsQlhHfV-0tcixJcZXH_ckqfG4Wh5XC355l5DnPf6sqcJxLfIVLmaPwurZ8cLy_NS3wuhFUOC46eDKoFVpnAtVIWVQhaokzIcnZNSxgu8SVEGlwh8trn3sPnKMb5JXe63hD7VUJjXgNcEUIgL1Bky1yNr0ByAYVuAaIPcGSJD3Yni740rf6psLj16GwGRYmZCn_W0ciTF0dVheRgwI5dga9Q-MhIUFt40DDR41jN6TUkgpwXsXCbEDERjQeninXnyJFculNsqqcUIOOmG58up_JejO_0P3ydbH11P_4e3x-11yS8R2JZzxdI9srs4vw2NwGlf5k6gbfgNKHWVa |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=European+cardiovascular+magnetic+resonance+%28EuroCMR%29+registry+-+multi+national+results+from+57+centers+in+15+countries&rft.jtitle=Journal+of+cardiovascular+magnetic+resonance&rft.au=Bruder%2C+Oliver&rft.au=Wagner%2C+Anja&rft.au=Lombardi%2C+Massimo&rft.au=Schwitter%2C+J%C3%BCrg&rft.date=2013-01-18&rft.pub=BioMed+Central&rft.issn=1097-6647&rft.eissn=1532-429X&rft.volume=15&rft_id=info:doi/10.1186%2F1532-429X-15-9&rft.externalDocID=2883758571 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1097-6647&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1097-6647&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1097-6647&client=summon |